- Home
- » Tags
- » Drug resistance
Top View
- Antimicrobial Resistance
- Drug Resistance
- ANTIMICROBIAL RESISTANCE Global Report on Surveillance
- Drug Resistance in Cancer: an Overview
- Antibacterial Agents in Clinical Development
- Antimicrobial Resistance and the Role of Vaccines
- Antibiotic Resistance and Distributive Justice
- Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
- Impact of Commonly Used Drugs on the Composition and Metabolic Function of the Gut Microbiota
- Mechanism of Drug Resistance in Mycobacterium Tuberculosis
- Antibiotics and the Mechanisms of Resistance to Antibiotics
- Antibacterial Discovery: 21St Century Challenges
- Transient Drug-Tolerance and Permanent Drug-Resistance Rely on the Trehalose-Catalytic Shift in Mycobacterium Tuberculosis
- Long Non-Coding Rnas Regulate Drug Resistance in Cancer Kaisheng Liu1†, Lin Gao1†, Xiaoshi Ma1†, Juan-Juan Huang2, Juan Chen1, Leli Zeng3,4, Charles R
- Antibiotic Resistance: Past, Present and Future
- Antibacterial Agents
- Chapter 5 Pharmacogenomics and Drug Transport/Efflux Arthur G
- Tpj201691.Pdf
- Evolution of Resistance to Cancer Therapy
- Drug Metabolism and Chemotherapy Resistance
- Drug-Resistance Enables Selective Killing of Resistant Leukemia Cells: Exploiting of Drug Resistance Instead of Reversal MV Blagosklonny
- Microbial Resistance and Biocides
- 2019 Antibacterial Agents in Clinical Development
- TB Drug Resistance in the U.S
- ANTIBIOTIC RESISTANCE THREATS in the United States, 2013
- Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Anticancer Therapies Concetta Panebianco, Angelo Andriulli and Valerio Pazienza*
- Pharmacogenetic Testing for Non-Cancer Indications
- The Pharmacology of Cancer Resistance
- Bacterial Resistance to Antimicrobial Agents
- Exploiting Drug Metabolism to Activate Immunity Against Cancer
- Ethics and Drug Resistance: Collective Responsibility for Global Public Health Public Health Ethics Analysis
- A Public Health Action Plan to Combat Antimicrobial Resistance
- Pharmacogenomics: Marshalling the Human Genome to Individualise Drug Therapy
- Overcoming Intrinsic and Acquired Resistance Mechanisms Associated with the Cell Wall of Gram-Negative Bacteria
- Status Report: Antibiotic Resistance in Maryland Addressing the Urgent Threats
- Multidrug-Resistant Tuberculosis (Mdr-Tb)
- Antimicrobial Adjuvants Drug Discovery, the Challenge of Avoid the Resistance and Recover the Susceptibility of Multidrug-Resistant Strains
- Drug Resistance in Malaria
- A Public Health Action Plan to Combat Antimicrobial Resistance
- Download [Last Accessed on 12 Feb 2020] 8
- Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens
- The Urgent Threat of TB Drug Resistance DRUGRESISTANT TB THREATENS to ERASE DECADES of PROGRESS
- Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment
- Antimicrobial Resistance
- Drug Resistance and Antibiotic Stewardship
- Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It
- Antimicrobials and Antibiotic-Resistant Bacteria: a Risk to the Environment and to Public Health
- Open Access Article Under the CC BY-NC-ND License (
- The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
- Drug Resistance: Part 1 What Is It; How to Measure and Interpret the Results? Next Issue: Drug Resistance: Part 2 Application to Clinical Practice